Status:
NOT_YET_RECRUITING
Enhancing Recovery Capital Amid Opioid Use Disorder Pharmacotherapy: A Pilot Randomized Trial
Lead Sponsor:
Massachusetts General Hospital
Conditions:
Opioid Use Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aims of the current study are to: Aim 1. Develop and refine a novel intervention protocol for individuals receiving medication treatment for opioid use disorder that assertively links them to reco...
Detailed Description
This 5-year project seek to advance our understanding of the clinical and public health utility of recovery community centers and help bridge the gap between clinical treatment and community-based rec...
Eligibility Criteria
Inclusion
- age ≥ 18 years
- past-year opioid use disorder diagnosis per the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition
- currently undergoing outpatient buprenorphine treatment through a provider or program at Massachusetts General Hospital
- current residence in Massachusetts
Exclusion
- non-English fluency
- active suicidality
- neurodevelopmental disorders or neural trauma preventing informed consent
- active psychosis
- past-year attendance at a recovery community center or recovery support center
Key Trial Info
Start Date :
December 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 28 2027
Estimated Enrollment :
145 Patients enrolled
Trial Details
Trial ID
NCT05245513
Start Date
December 1 2025
End Date
February 28 2027
Last Update
September 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114